Tech Company Financing Transactions
Sequoia Sciences Funding Round
Sequoia Sciences, operating out of St. Louis, received investment from Holton Capital Group and Prolog Ventures.
Transaction Overview
Company Name
Announced On
12/28/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Prolog Ventures (Brian Clevinger)
Proceeds Purpose
The capital will enable the St. Louis startup to test the vaccine in a clinical trial.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1912 Innerbelt Business Center Dr.
St. Louis, MO 63114
USA
St. Louis, MO 63114
USA
Phone
Website
Email Address
Overview
From a collection of natural product compounds isolated from plants, Sequoia has identified compounds that may potentially provide new and alternative treatments for acute bacterial infections and chronic infections involving bacterial biofilms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Stephen Trampe
Chief Executive Officer
Gary Eldridge
Vice President
Mark O'Neil-Johnson
Browse more venture capital transactions:
Prev: 12/28/2012: Cozi Group venture capital transaction
Next: 12/28/2012: Cheezburger venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs